We are seeking a Head of IT for our biotech production site and Headquarters in Meyrin. Reporting directly to the Chief Technical Officer, you will lead a team of 17 people. Your mission is to define and drive the IT vision and strategy, and to ensure robust, secure and compliant IT operations that effectively support business priorities and enterprise digital initiatives.
Your main responsibilities are as follows:
To carry out this mission, we are looking for an hands-on candidate bringing the following profile:
You are a servant leader with a strong entrepreneurial mindset, combining strategic thinking with pragmatic execution. You communicate with impact, build trust across functions, and are comfortable influencing senior stakeholders while remaining close to operations. You thrive in dynamic and regulated environments, bring structure without losing agility, and consistently seek solutions that strengthen performance, compliance and business value.
If you want to have a tangible impact on business performance by shaping and leading an IT function, we look forward to receiving your application.
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.
For more information, visit the website: ompharma.com

We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance.
Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates.
Headquartered in Geneva with affiliates in Peru and Switzerland, our products are available in more than 100 countries through a network of trusted partners.